MedWatch Offers Safety Alerts via Text

Staff Writer
Published: Wednesday, Jun 02, 2010
The FDA has added text messaging to the ranks of e-mail digests, RSS feeds, podcasts, and Websites that comprise MedWatch, the agency’s safety information and adverse event reporting program. The free 6-month pilot program sends registrants 3 to 5 weekly safety alerts. Signing up for MedWatch texts can keep busy oncologists informed on FDA safety concerns regarding medications, vaccines, and medical devices. Messages can be tailored during registration to suit individual needs. According to MedWatch medical director Norman S. Marks, MD, MHA, the service is the first step toward delivering targeted, patient-specific information that can be used to impact decisions at the point of care. The FDA’s ultimate aspiration, Marks said in a press statement, is for drug-specific safety alerts to coordinate with patients’ electronic health records. To sign up for the service, text FDA in the body of the message to 87000. While the FDA does not charge subscribers to participate in this pilot program, standard text messaging rates from the subscriber’s wireless carrier may apply. For more information on MedWatch, visit

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Bridging the Gaps Around Oncology Biosimilars: Assessing the Potential Impact of Emerging Agents to PracticeSep 29, 20181.5
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication